Magnetoencephalography in Children

Study Purpose

This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.

Recruitment Criteria

Accepts Healthy Volunteers

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

No
Study Type

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Observational [Patient Registry]
Eligible Ages 1 Month - 18 Years
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

1. aged 1 month-18 years old (date of investigate minus date of birth) 2. epilepsy. 3. intracranial tumors. 4. cerebrovascular diseases. 5. autism. 6. mental retardation. 7. ADHD. 8. tic disorder. 9. neuropsychiatric disorders.

Exclusion Criteria:

1.Unable to cooperate with the exam of MEG

Trial Details

Trial ID:

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

NCT06668519
Phase

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Lead Sponsor

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Children's Hospital of Fudan University
Principal Investigator

The person who is responsible for the scientific and technical direction of the entire clinical study.

N/A
Principal Investigator Affiliation N/A
Agency Class

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Other
Overall Status Recruiting
Countries China
Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Epilepsy, Intracranial Tumors, Cerebrovascular Disease, Autism, ADHD - Attention Deficit Disorder With Hyperactivity, Neuropsychiatric Disorders, Tic Disorder, Childhood, Mental Retardation, Developmental Disabilities
Additional Details

The purpose of this study is to observe the application of magnetoencephalography (MEG) in pediatric neurodevelopmental disorders

Arms & Interventions

Arms

: children with neurodevelopmental diseases

: healthy children

Interventions

Other: - Magnetoencephalography

Magnetoencephalography

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

Children's Hospital of Fudan University, Shanghai, China

Status

Recruiting

Address

Children's Hospital of Fudan University

Shanghai, , 201102

Site Contact

yuanfeng Zhou

[email protected]

18916152087

Stay Informed & Connected